Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.
Dasgupta A, Gupta T, Maitre M, Kalra B, Chatterjee A, Krishnatry R, Goda JS, Shirsat N, Epari S, Sahay A, Janu A, Pungavkar S, Chinnaswamy G, Patil V, Moiyadi A, Shetty P, Jalali R. Dasgupta A, et al. Among authors: janu a. Strahlenther Onkol. 2022 Mar;198(3):291-303. doi: 10.1007/s00066-021-01889-9. Epub 2022 Jan 21. Strahlenther Onkol. 2022. PMID: 35059761
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients.
Noronha V, Joshi A, Gokarn A, Sharma V, Patil V, Janu A, Purandare N, Chougule A, Jambhekar N, Prabhash K. Noronha V, et al. Among authors: janu a. Chemother Res Pract. 2014;2014:856156. doi: 10.1155/2014/856156. Epub 2014 Dec 7. Chemother Res Pract. 2014. PMID: 25548673 Free PMC article.
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapy.
Noronha V, Patil V, Joshi A, Chougule A, Bhattacharjee A, Kumar R, More S, Goud S, Karpe A, Ramaswamy A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K. Noronha V, et al. Among authors: janu a. Ecancermedicalscience. 2017 Oct 24;11:776. doi: 10.3332/ecancer.2017.776. eCollection 2017. Ecancermedicalscience. 2017. PMID: 29104613 Free PMC article.
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?
Joshi A, Noronha V, Patil VM, Chougule A, Bhattacharjee A, Kumar R, Goud S, More S, Ramaswamy A, Karpe A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K. Joshi A, et al. Among authors: janu a. Chemother Res Pract. 2017;2017:8196434. doi: 10.1155/2017/8196434. Epub 2017 Oct 23. Chemother Res Pract. 2017. PMID: 29201462 Free PMC article.
99 results